Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Week in Review: ELVIS in the OR | Cardiology leaders oppose Trump policy | COVID-19 updates | Genetic testing
Saturday, July 25, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Top Stories

Signs of COVID-19 still in blood sample 40 days after symptom resolution

“This case should be taken into consideration as blood donation policies are being crafted," the researchers wrote. 

READ MORE >
Blood Test Tube
Share on Twitter Share on Facebook Share on Linkedin

Signs of COVID-19 still in blood sample 40 days after symptom resolution

Share on Twitter Share on Facebook Share on Linkedin
Blood Test Tube
“This case should be taken into consideration as blood donation policies are being crafted," the researchers wrote. 
READ MORE >

Meet ELVIS, the holographic display that improves cardiologist accuracy

ELVIS, it seems, has entered the operating room. 

READ MORE >
hologram operating room
Share on Twitter Share on Facebook Share on Linkedin

Meet ELVIS, the holographic display that improves cardiologist accuracy

Share on Twitter Share on Facebook Share on Linkedin
hologram operating room
ELVIS, it seems, has entered the operating room. 
READ MORE >

Cardiology one of healthcare’s top specialties when it comes to net worth, paying off debt

Nearly half of all cardiologists have a net worth between $1 million and $5 million, according to a new report from Medscape.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Cardiology one of healthcare’s top specialties when it comes to net worth, paying off debt

Share on Twitter Share on Facebook Share on Linkedin
Nearly half of all cardiologists have a net worth between $1 million and $5 million, according to a new report from Medscape.
READ MORE >

American College of Cardiology ‘disappointed’ by Trump’s decision to exit WHO

“Diseases don't respect geographic and political boundaries," wrote ACC President Athena Poppas, MD, and others. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

American College of Cardiology ‘disappointed’ by Trump’s decision to exit WHO

Share on Twitter Share on Facebook Share on Linkedin
“Diseases don't respect geographic and political boundaries," wrote ACC President Athena Poppas, MD, and others. 
READ MORE >

What cardiologists know, and don’t know, about genetic testing for heart disease

Such testing typically makes the most sense when patients have a confirmed diagnosis of an inherited cardiovascular disease or an abnormality has already been identified.

READ MORE >
DNA Puzzle
Share on Twitter Share on Facebook Share on Linkedin

What cardiologists know, and don’t know, about genetic testing for heart disease

Share on Twitter Share on Facebook Share on Linkedin
DNA Puzzle
Such testing typically makes the most sense when patients have a confirmed diagnosis of an inherited cardiovascular disease or an abnormality has already been identified.
READ MORE >

Featured Articles

COVID-19’s impact on heart transplants in the US: 4 key statistics

Researchers explored everything from waitlist additions to deceased donor recoveries, sharing their findings in JAMA Cardiology. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

COVID-19’s impact on heart transplants in the US: 4 key statistics

Share on Twitter Share on Facebook Share on Linkedin
Researchers explored everything from waitlist additions to deceased donor recoveries, sharing their findings in JAMA Cardiology. 
READ MORE >

World’s smallest endoscope could make a big difference in fight against heart disease

Researchers have developed what they believe is the world’s smallest imaging device, a microscopic endoscope capable of scanning the inside of blood vessels.

READ MORE >
Endoscope
Share on Twitter Share on Facebook Share on Linkedin

World’s smallest endoscope could make a big difference in fight against heart disease

Share on Twitter Share on Facebook Share on Linkedin
Endoscope
Researchers have developed what they believe is the world’s smallest imaging device, a microscopic endoscope capable of scanning the inside of blood vessels.
READ MORE >

Treating heart failure during a pandemic: 3 key recommendations

A new commentary in Circulation: Heart Failure offers a first-hand account of how one facility embraced telehealth and faced the pandemic head-on.

READ MORE >
Telemedicine
Share on Twitter Share on Facebook Share on Linkedin

Treating heart failure during a pandemic: 3 key recommendations

Share on Twitter Share on Facebook Share on Linkedin
Telemedicine
A new commentary in Circulation: Heart Failure offers a first-hand account of how one facility embraced telehealth and faced the pandemic head-on.
READ MORE >

Adding alirocumab to high-intensity statin therapy benefits older ACS patients

This new analysis of the ODYSSEY OUTCOMES trial includes data from more than 18,000 patients. 

READ MORE >
Elderly
Share on Twitter Share on Facebook Share on Linkedin

Adding alirocumab to high-intensity statin therapy benefits older ACS patients

Share on Twitter Share on Facebook Share on Linkedin
Elderly
This new analysis of the ODYSSEY OUTCOMES trial includes data from more than 18,000 patients. 
READ MORE >

Unnecessary care: Levothyroxine ineffective for heart attack patients with subclinical hypothyroidism

The ThyrAMI-2 trial tracked 95 patients for 52 weeks of treatment. 

READ MORE >
heart
Share on Twitter Share on Facebook Share on Linkedin

Unnecessary care: Levothyroxine ineffective for heart attack patients with subclinical hypothyroidism

Share on Twitter Share on Facebook Share on Linkedin
heart
The ThyrAMI-2 trial tracked 95 patients for 52 weeks of treatment. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme